Search scope:
排序: Display mode:
Lu Jinyou,Huang Yue,Wang Jun
Strategic Study of CAE 2011, Volume 13, Issue 7, Pages 129-136
According to the measured data after impoundment and operation of theanalysis that the reservoir sediment deposition and downstream river channel scouring during 8-year impoundment
Keywords: Three Gorges Project trial impoundment reservoir sediment deposition downstream river channel scouring
Trial design of arch bridge of composite box section with steel web-concrete flange
Jiangang WEI, Qingwei HUANG, Baochun CHEN,
Frontiers of Structural and Civil Engineering 2010, Volume 4, Issue 3, Pages 370-375 doi: 10.1007/s11709-010-0073-7
Keywords: steel webs concrete box arch trial design structural behaviors finite element method
Balancing method without trial weights for rotor systems based on similitude scale model
Ruiduo YE, Liping WANG, Xiaojie HOU, Zhong LUO, Qingkai HAN
Frontiers of Mechanical Engineering 2018, Volume 13, Issue 4, Pages 571-580 doi: 10.1007/s11465-018-0478-x
A balancing method without trial weights based on the dynamic similitude scale model was proposedThe balancing method without trial weights was proposed based on the similitude relationship of the influenceThe effect of the balancing method without trial weights was compared with that of the traditional influence
Keywords: rotor system dynamic similitude balancing without trial weights influence coefficient
Development and clinical trial of a novel bioactive bone cement
LEONG John, LI Zhaoyang, LU William
Frontiers of Medicine 2008, Volume 2, Issue 2, Pages 117-126 doi: 10.1007/s11684-008-0022-1
Keywords: bioactivity effectiveness strontium-containing hydroxyapatite osseointegration sufficient mechanical
Frontiers of Medicine doi: 10.1007/s11684-023-1001-2
Keywords: iron deficiency anemia intravenous iron ferric carboxymaltose iron sucrose Hb response early response
Frontiers of Medicine 2021, Volume 15, Issue 3, Pages 460-471 doi: 10.1007/s11684-021-0861-6
Keywords: low-carbohydrate diet obesity nonalcoholic fatty liver disease continuous glucose monitoring mean sensor glucose
Shilin DENG MD ,
Frontiers of Medicine 2009, Volume 3, Issue 3, Pages 323-329 doi: 10.1007/s11684-009-0061-2
Keywords: early postmenopausal women bone mineral density exercise effects
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 93-104 doi: 10.1007/s11684-021-0892-z
Keywords: chemotherapy cervical cancer lymph node metastasis concurrent chemoradiotherapy quality of life
Immunosuppression and Liver Transplantation Review
Jan Lerut, Samuele Iesari
Engineering 2023, Volume 21, Issue 2, Pages 175-187 doi: 10.1016/j.eng.2022.07.007
Perfect surgical techniques and adequate immunosuppression are key to ensuring optimal graft and patient survival. The availability of different drugs has led to several, often industry-driven, heterogeneous clinical trials to discover an ideal immunosuppressive regimen. However, the considerable and conceptually diverse study designs have failed to afford a clear definition of the optimal immunosuppression regimen. The triple-drug immunosuppressive regimen, based on the calcineurin inhibitor tacrolimus, antimetabolites mofetil mycophenolate or azathioprine, and short-term steroids—beyond possible induction—remains the currently accepted standard immunosuppression in liver transplantation. However, this regimen needs to be challenged in light of the changing definitions of rejection, customization of the immunosuppressive load, and long-term side effects due to chronic immunosuppression. Future trials should preferably include more than a single endpoint rather than acute T-cell-mediated acute rejection (a-TCMR) or kidney failure. Conversely, a comprehensive endpoint that covers patient and graft survival rates and the incidence of both acute and chronic rejection is warranted. These immune phenomena should be examined in light of serial long-term biological and histological follow-up. The diagnosis and treatment of clinically relevant a-TCMR should be based on integrated biological, immunological, and histopathological findings. Both elements are critical to progress toward more prudent immunosuppression handling and favor clinical operational tolerance.
Keywords: Liver transplantation Immunosuppression Rejection Tolerance Clinical trial
Natural Killer Cell-Based Immunotherapy for Cancer: Advances and Prospects Review
Yuan Hu, Zhigang Tian, Cai Zhang
Engineering 2019, Volume 5, Issue 1, Pages 106-114 doi: 10.1016/j.eng.2018.11.015
Natural killer (NK) cells are key innate immune cells that provide the first line of defense against viral infection and cancer. Although NK cells can discriminate between "self" and "non-self," recognize abnormal cells, and eliminate transformed cells and malignancies in real time, tumors develop several strategies to escape from NK cell attack. These strategies include upregulating ligands for the inhibitory receptors of NK cells and producing soluble molecules or immunosuppressive factors. Various types of NK cells are currently being applied in clinical trials, including autologous or allogeneic NK cells, umbilical cord blood (UCB) or induced pluripotent stem cell (iPSC)-derived NK cells, memory-like NK cells, and NK cell line NK-92 cells, for the treatment of different types of tumors. Chimeric antigen receptors (CARs)-NK cells have recently shown great potential due to their redirect specificity and effective antitumor activity. In this review, we summarize the mechanisms of tumor escape from NK cell recognition, the current status and advanced progress of NK cell-based immunotherapy, ways of enhancing the antitumor capacity of NK cells in vivo, and major challenges for clinical practice in this field.
Keywords: Natural killer cell Immunotherapy Cancer Clinical trial Chimeric antigen receptor
Shuyang Sun,Zhiyuan Zhang
Frontiers of Medicine 2016, Volume 10, Issue 1, Pages 104-110 doi: 10.1007/s11684-016-0432-4
Advances in next-generation sequencing and bioinformatics have begun to reveal the complex genetic landscape in human cancer genomes, including oral squamous cell carcinoma (OSCC). Sophisticated preclinical models that fully represent intra- and inter-tumoral heterogeneity are required to understand the molecular diversity of cancer and achieve the goal of personalized therapies. Patient-derived xenograft (PDX) models generated from human tumor samples that can retain the histological and genetic features of their donor tumors have been shown to be the preferred preclinical tool in translational cancer research compared with other conventional preclinical models. Specifically, genetically well-defined PDX models can be applied to accelerate targeted antitumor drug development and biomarker discovery. Recently, we have successfully established and characterized an OSCC PDX panel as part of our tumor bio-bank for translational cancer research. In this paper, we discuss the establishment, characterization, and preclinical applications of the PDX models. In particular, we focus on the classification and applications of the PDX models based on validated annotations, including clinicopathological features, genomic profiles, and pharmacological testing information. We also explore the translational value of this well-annotated PDX panel in the development of co-clinical trials for patient stratification and treatment optimization in the near future. Although various limitations still exist, this preclinical approach should be further tested and improved.
Keywords: patient-derived xenograft models personalized medicine co-clinical trial patient stratification oral
Frontiers of Medicine 2022, Volume 16, Issue 2, Pages 276-284 doi: 10.1007/s11684-021-0855-4
Keywords: gestational trophoblastic neoplasia (GTN) methotrexate (MTX) dactinomycin (ACTD)
Yang Liu, Xinjie Yu, Leilei Yu, Fengwei Tian, Jianxin Zhao, Hao Zhang, Long Qian, Qun Wang, Zhengqing Xue, Qixiao Zhai, Wei Chen
Engineering 2021, Volume 7, Issue 3, Pages 376-385 doi: 10.1016/j.eng.2020.06.026
Keywords: Lactobacillus plantarum Irritable bowel syndrome Gut microbiota Butyric acid Clinical trial
Feasibility of using wind turbines for renewable hydrogen production in Firuzkuh, Iran
Ali MOSTAFAEIPOUR, Mojtaba QOLIPOUR, Hossein GOUDARZI
Frontiers in Energy 2019, Volume 13, Issue 3, Pages 494-505 doi: 10.1007/s11708-018-0534-6
Keywords: wind turbine hydrogen production HOMER software decision making trial and evaluation (DEMATEL) data envelopment
The boron neutorn capture therapy (BNCT) status to go into the new era
Zhou Yongmao
Strategic Study of CAE 2012, Volume 14, Issue 8, Pages 4-13
The paper briefly interprets the obvious progress of the boron neutorn capture therapy (BNCT) in the new era. It includes the BNCT clinical positioning, the tumour recurrence exploring, the boron concentration quantifed detecting, the targeting boron compound composing and the in hospitor neutron source irradintors setting up. The enlargement of these bottle necks in BNCT developing might be the preview of personalizing and routine BNCT.
Keywords: neutron capture therapy clinical trial tumour recurrence boron concentration detect targeting boron
Title Author Date Type Operation
The analysis on reservoir sediment deposition and downstream river channel scouring after impoundment
Lu Jinyou,Huang Yue,Wang Jun
Journal Article
Trial design of arch bridge of composite box section with steel web-concrete flange
Jiangang WEI, Qingwei HUANG, Baochun CHEN,
Journal Article
Balancing method without trial weights for rotor systems based on similitude scale model
Ruiduo YE, Liping WANG, Xiaojie HOU, Zhong LUO, Qingkai HAN
Journal Article
Development and clinical trial of a novel bioactive bone cement
LEONG John, LI Zhaoyang, LU William
Journal Article
A randomized, controlled, open label non-inferiority trial of intravenous ferric carboxymaltose versus
Journal Article
diets lead to greater weight loss and better glucose homeostasis than exercise: a randomized clinical trial
Journal Article
Effects of exercise therapy on bone mineral density in early postmenopausal women: a controlled trial
Shilin DENG MD ,
Journal Article
chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial
Journal Article
Natural Killer Cell-Based Immunotherapy for Cancer: Advances and Prospects
Yuan Hu, Zhigang Tian, Cai Zhang
Journal Article
Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization
Shuyang Sun,Zhiyuan Zhang
Journal Article
methotrexate for low-risk gestational trophoblastic neoplasia: a multi-centric randomized clinical trial
Journal Article
and Prevents Gut Microbiota Dysbiosis: A Randomized, Double-blind, Placebo-controlled, Pilot Clinical Trial
Yang Liu, Xinjie Yu, Leilei Yu, Fengwei Tian, Jianxin Zhao, Hao Zhang, Long Qian, Qun Wang, Zhengqing Xue, Qixiao Zhai, Wei Chen
Journal Article
Feasibility of using wind turbines for renewable hydrogen production in Firuzkuh, Iran
Ali MOSTAFAEIPOUR, Mojtaba QOLIPOUR, Hossein GOUDARZI
Journal Article